Novavax coronavirus vaccine becomes fifth to begin Phase 3 trials in United States

Novavax on Monday...

Posted: Dec 28, 2020 10:10 AM
Updated: Dec 29, 2020 12:15 AM

Novavax on Monday announced the start of the Phase 3 trial of its Covid-19 vaccine in the United States and Mexico. It is the fifth company to launch a large-scale trial of a coronavirus vaccine in the United States.

The trial for the vaccine candidate, known as NVX-CoV2373, will evaluate safety, efficacy and immune response in up to 30,000 people age 18 and older. It builds on Phase 1/2 studies that demonstrated that the vaccine provoked an immune response and appeared to be safe.

The trial is examining whether the vaccine prevents Covid-19 symptoms, as well as moderate or severe Covid-19 symptoms. All participants will be followed for 24 months following their second injection.

Two-thirds of participants will be assigned to randomly receive two injections of vaccine administered 21 days apart, the remaining one-third will receive a placebo. The trials sites are in locations that currently have high transmission rates 'to accelerate the accumulation of positive cases that could show efficacy,' the release says.

Novavax says it aims for at least 25% of the study population to be age 65 or older, at least 15% to be Black, at least 10 to 20% Latinx and 1-2% American Indian.

'With the COVID-19 pandemic raging around the globe, this trial is a critical step in building the global portfolio of safe and effective vaccines to protect the world's population,' Stanley C. Erck, president and chief executive officer of Novavax, said in a news release.

The trial is being funded with up to $1.6 billion from Operation Warp Speed.

Novavax is also currently conducting a Phase 3 clinical study in the United Kingdom, a Phase 2b trial in South Africa and a Phase 1/2 continuation in the US and Australia, data from which are expected as soon as early first quarter 2021.

Two vaccines, from Pfizer/BioNTech and Moderna, have received emergency use authorization from the US Food and Drug Administration. Both began Phase 3 trials in the US in July and enrolled over 30,000 participants. Both are two dose vaccines and have been shown to have 95% and 94.1% efficacy respectively.

AstraZeneca began the Phase 3 US trial of its coronavirus vaccine in September. Johnson & Johnson, which is testing a single-dose vaccines, expects efficacy results from its Phase 3 trial by January or February.

Oregon Coronavirus Cases

Data is updated nightly.

Cases: 155597

Reported Deaths: 2208
CountyCasesDeaths
Multnomah31877528
Washington21211212
Marion18468285
Clackamas13380175
Lane10258126
Jackson8395112
Umatilla765982
Deschutes595259
Yamhill378364
Linn359056
Malheur335158
Polk306442
Klamath279155
Douglas247454
Benton234416
Josephine234050
Jefferson195828
Coos149119
Union128419
Columbia126521
Wasco122126
Lincoln113220
Hood River106929
Morrow104914
Clatsop7756
Crook77518
Baker6567
Curry4296
Tillamook4142
Lake3766
Harney2736
Grant2231
Wallowa1424
Gilliam531
Sherman530
Wheeler221
Unassigned00

California Coronavirus Cases

Data is updated nightly.

Cases: 3566914

Reported Deaths: 52158
CountyCasesDeaths
Los Angeles119192321435
Riverside2894503767
San Bernardino2866072874
Orange2612203917
San Diego2600913284
Santa Clara1106211777
Kern102627827
Fresno953931443
Sacramento932811472
Alameda806681242
Ventura77623844
San Joaquin665691101
Contra Costa62248681
Stanislaus56132946
Tulare47784758
Monterey42138328
San Mateo38998515
San Francisco34260412
Santa Barbara31805411
Solano30024164
Merced28915397
Sonoma28141298
Imperial26903591
Kings21955218
Placer19763232
San Luis Obispo19612227
Madera15467209
Santa Cruz14588183
Marin13136197
Yolo12834185
Shasta10985174
Butte10962160
El Dorado9095100
Napa903869
Sutter884597
San Benito576759
Yuba573337
Lassen560119
Tehama508152
Nevada396074
Tuolumne394659
Mendocino379643
Amador346341
Humboldt318033
Lake315641
Glenn222523
Colusa212813
Calaveras190547
Siskiyou174014
Inyo128737
Mono12114
Del Norte9875
Plumas6536
Modoc4524
Mariposa3957
Trinity3675
Sierra990
Alpine810
Unassigned00
Medford
Clear
47° wxIcon
Hi: 63° Lo: 30°
Feels Like: 47°
Brookings
Clear
43° wxIcon
Hi: 57° Lo: 37°
Feels Like: 43°
Medford
Clear
47° wxIcon
Hi: 39° Lo: 18°
Feels Like: 47°
Medford
Partly Cloudy
47° wxIcon
Hi: 65° Lo: 30°
Feels Like: 47°
Klamath Falls
Clear
30° wxIcon
Hi: 50° Lo: 23°
Feels Like: 25°
Very mild start to March
KDRV Radar
KDRV Fire Danger
KDRV Weather Cam

Community Events